< Back

'visual field study' (ICD9CM: 95.05)
Run an advanced search on this term

Search within:  

Sort results by:      



1-20 of 358   Next >
 
1.  
Screening for glaucoma: U.S. Preventive Services Task Force recommendation statement. 2005 Mar 29 (revised 2013 Oct 1). NGC:009944
U.S. Preventive Services Task Force - Independent Expert Panel. View all guidelines by the developer(s)
2.  
Glaucoma. In: Guidelines for preventive activities in general practice, 8th edition. 2012. NGC:009650
Royal Australian College of General Practitioners - Professional Association. View all guidelines by the developer(s)
3.  
Evidence-based clinical practice guideline: eye care of the patient with diabetes mellitus. 1993 (revised 2014). NGC:010318
American Optometric Association - Professional Association. View all guidelines by the developer(s)
4.  
5.  
6.  
Acromegaly: an Endocrine Society clinical practice guideline. 2014 Nov. NGC:010692
The Endocrine Society - Professional Association. View all guidelines by the developer(s)
7.  
8.  
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly—2011 update. 2004 May-Jun (revised 2011 Jul-Aug). NGC:008885
American Association of Clinical Endocrinologists - Medical Specialty Society. View all guidelines by the developer(s)
9.  
Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion. 2014 Feb. NGC:010285
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
10.  
Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion. 2013 May. NGC:009895
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
11.  
ACR Appropriateness Criteria® orbits, vision and visual loss. 1999 (revised 2012). NGC:009239
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
12.  
13.  
Ranibizumab for treating choroidal neovascularisation associated with pathological myopia. 2013 Nov. NGC:010190
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
14.  
Amblyopia. 1992 Feb (revised 2012). NGC:009506
American Academy of Ophthalmology - Medical Specialty Society. View all guidelines by the developer(s)
15.  
Ranibizumab for treating diabetic macular oedema (rapid review of technology appraisal guidance 237). 2013 Apr. NGC:009630
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
16.  
Aflibercept for treating diabetic macular oedema. 2015 Jul. NGC:010771
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
17.  
Vision screening for children 1 to 5 years of age: U.S. Preventive Services Task Force recommendation statement. 1996 (revised 2011 Feb). NGC:008226
U.S. Preventive Services Task Force - Independent Expert Panel. View all guidelines by the developer(s)
18.  
Cataract in the adult eye. 1996 Sep (revised 2011 Sep). NGC:008993
American Academy of Ophthalmology - Medical Specialty Society. View all guidelines by the developer(s)
19.  
Esotropia and exotropia. 1992 Feb (revised 2012). NGC:009507
American Academy of Ophthalmology - Medical Specialty Society. View all guidelines by the developer(s)
20.  
Glaucoma referral and safe discharge. A national clinical guideline. 2015 Mar. NGC:010804
Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
1-20 of 358   Next >